Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization
Aging Cell · 2026
DOI: 10.1111/acel.70379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Xiaoling Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xuanwu Hospital, National Clinical Research Center for Geriatric Disorders, Capital Medical University, Beijing, C…. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Amyloid Precursor Protein Secretases, Amyloid beta-Protein Precursor, Aspartic Acid Endopeptidases. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Program of the National Natural Science Foundation of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Synaptic vesicle glycoprotein 2A (SV2A), a transmembrane protein widely localized to synaptic vesicles, serves as a key indicator of synaptic loss in Alzheimer's disease (AD). In this study, adeno‐associated virus (AAV) was injected by brain stereotactic injection technique to construct SV2A‐overexpressing APP/PS1 mice, then the effects of SV2A on amyloid precursor protein (APP) degradation and its molecular mechanism were further explored in vivo or in vitro. Our results demonstrated that SV2A overexpression significantly reduced Aβ plaque deposition in brain tissue of APP/PS1 mice. Mechanistically, SV2A was identified as a novel APP‐binding protein that attenuated the amyloidogenic processing of APP by inhibiting its interaction with β‐site APP cleaving enzyme 1 (BACE1). Furthermore, SV2A overexpression altered the subcellular distribution of APP, shifting its localization away from the endosomal‐lysosomal compartments. Collectively, our findings unveil SV2A as a critical regulator of APP metabolism and propose it as a promising therapeutic target for intervening in the early pathological progression of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Xuanwu Hospital, National Clinical Research Center for Geriatric Disorders, Capital Medical University, Beijing, China.
- Department of Clinical Laboratory, Changzhi People's Hospital of Changzhi Medical College, Changzhi, Shanxi, China.
- Department of Clinical Laboratory, Beijing Huairou Hospital, Beijing, China.
ORCID-Profile: Jing Liu, Yaqi Wang, Peichang Wang
Förderung
- State Key Program of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- HUIZHI Talent Leadership Development Program of Xuanwu Hospital
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, X., Zhang, Q., Zhang, X., Liu, J., Zhang, J., Liu, C., Cui, Y., Song, Q., Hou, Y., Wang, Y., Cao, M., & Wang, P. (2026). Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization. Aging Cell. https://doi.org/10.1111/acel.70379
Vancouver
Wang X, Zhang Q, Zhang X, Liu J, Zhang J, Liu C, et al. Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization. Aging Cell. 2026. doi:10.1111/acel.70379
BibTeX
@article{Wang2026,
author = {Wang, Xiaoling and Zhang, Qian and Zhang, Xiaomin and Liu, Jing and Zhang, Jingjing and Liu, Congcong and Cui, Yuting and Song, Qiao and Hou, Yuli and Wang, Yaqi and Cao, Min and Wang, Peichang},
title = {Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70379}
}
EUVIMED